Patents by Inventor Katarina Drakenberg

Katarina Drakenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and methods for treatment of hepatitis C
    Patent number: 7837996
    Abstract: The present invention relates to materials and methods for treatment of hepatitis C. More closely, the invention relates to human monoclonal antibodies against HCV E1 antigen, to a reagent comprising such antibodies, and to vaccine compositions comprising such antibodies. Furthermore, the invention relates to a method of treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: November 23, 2010
    Assignee: Molecules of Man AB
    Inventors: Katarina Drakenberg, Mats A. A. Persson
  • MATERIALS AND METHODS FOR TREATMENT OF HEPATITIS C
    Publication number: 20090162373
    Abstract: The present invention relates to materials and methods for treatment of hepatitis C. More closely, the invention relates to human monoclonal antibodies against HCV E1 antigen, to a reagent comprising such antibodies, and to vaccine compositions comprising such antibodies. Furthermore, the invention relates to a method of treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention.
    Type: Application
    Filed: July 6, 2007
    Publication date: June 25, 2009
    Inventors: Katarina Drakenberg, Mats A.A. Persson
  • Human monoclonal antibodies that bind hepatitis C virus (HCV) E1
    Patent number: 7250166
    Abstract: The present invention relates to materials and methods for treatment of hepatitis C. More closely, the invention relates to human monoclonal antibodies against HCV E1 antigen, to a reagent comprising such antibodies, and to vaccine compositions comprising such antibodies. Futhermore, the invention relates to a method of treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: July 31, 2007
    Assignee: Molecules of Man AB
    Inventors: Katarina Drakenberg, Mats A. A. Persson